The protective effect of erdosteine against cyclosporine A-induced cardiotoxicity in rats

Toxicology

Volumn 239, Issue 1-2, 2007, Pages 53-59

  Selcoki, Yusuf ^a   Uz, Ebru ^a   Bayrak, Reyhan ^a   Sahin, Semsettin ^b   Kaya, Arif ^a   Uz, Burak ^a   Karanfil, Aydin ^a   Ozkara, Adem ^a   Akcay, Ali ^a  

^a FATIH UNIVERSITY   (Turkey)

^b GAZIOSMANPASA UNIVERSITY   (Turkey)

Author keywords

Cardiotoxicity; Catalase; Cyclosporine; Erdosteine; Glutathione peroxidase; Malondialdehyde; Nitric oxide; Protein carbonyl; Superoxide dismutase

Indexed keywords

CARBONYL DERIVATIVE; CATALASE; CYCLOSPORIN A; ERDOSTEINE; GLUTATHIONE PEROXIDASE; MALONALDEHYDE; NITRIC OXIDE; SUPEROXIDE DISMUTASE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CARDIOTOXICITY; CELL CONTACT; CELL COUNT; CONTROLLED STUDY; ENZYME ACTIVITY; FIBROSING ALVEOLITIS; HEART INJURY; HEART MUSCLE CELL; HEART PROTECTION; MALE; MICROSCOPY; NONHUMAN; PRIORITY JOURNAL; RAT;

ANIMALS; CATALASE; CHEMOPREVENTION; CYCLOSPORINE; DISEASE MODELS, ANIMAL; EXPECTORANTS; FIBROSIS; GLUTATHIONE PEROXIDASE; HEART; HEART DISEASES; IMMUNOSUPPRESSIVE AGENTS; MALE; MALONDIALDEHYDE; MYOCARDIUM; NITRIC OXIDE; OXIDATIVE STRESS; PROTEIN CARBONYLATION; RATS; RATS, WISTAR; SUPEROXIDE DISMUTASE; THIOGLYCOLATES; THIOPHENES;

RATTUS;

EID: 34548051114     PISSN: 0300483X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.tox.2007.06.096     Document Type: Article

References (33)

1. Abuja P.M., and Albertini R. Methods for monitoring oxidative stress, lipid peroxidation and oxidation resistance of lipoproteins. Clin. Chim. Acta 306 (2001) 1-17
2. Aebi H. Catalase. In: Bergmeyer H.U. (Ed). Methods of Enzymatic Analysis (1974), Academic Press, New York and London 673-677
3. Akyol O., Herken H., Uz E., Fadilhoglu E., Ural S., and Sogut S. The indices of endogenous oxidative and antioxidative processes in plasma from schizophrenic patients. The possible role of oxidant/antioxidant imbalance. Prog. Neuropsychopharmacol. Biol. Psychiatr. 26 (2002) 995-1005
4. Bianchi R., Rodella L., and Rezzani R. Cyclosporine A up-regulates expression of matrix matalloproteinase 2 and vascular endotelial growth factor in rat heart. Int. Immunopharmacol. 3 (2003) 427-433
5. Boyaci H., Maral H., Turan G., Basyigit I., Dillioglugil M.O., Yildiz F., Tugay M., Pala A., and Ercin C. Effects of erdosteine on bleomycin-induced lung fibrosis in rats. Mol. Cell. Biochem. (2006)
6. Braga P.C., Dal Sasso M., and Zuccotti T. Assessment of the antioxidant activity of the SH metabolite I of erdostein on human neutrophil oxidative bursts. Arzneimittelforschung 50 (2000) 739-746
7. Cortas N.K., and Wakid N.W. Determination of inorganic nitrate in serum and urine by a kinetic cadmium-reduction method. Clin. Chem. 36 (1990) 1440-1443
8. Dalle-Donne I., Giustarini D., Colombo R., Rossi R., and Milzani A. Protein carbonylation in human diseases. Trends Mol. Med. 9 (2003) 169-176
9. Dechant K.L., and Noble S. Erdostein. Drugs 52 (1996) 875-881
10. Durak I., Yurtarslani Z., Canbolat O., and Akyol O. A methodological approach to superoxide dismutase activity assay based on inhibition of nitroblue tetrazoline reduction. Clin. Chim. Acta 214 (1993) 103-104
11. Ege E., Ilhan A., Gurel A., Akyol O., and Ozen S. Erdosteine ameliorates neuro-logical outcome and oxidative stress due to ischemia/reperfusion injury in rabbit spinal cord. Eur. J. Vasc. Endovasc. Surg. 28 (2004) 379-386
12. Erlanger B.F. Why cyclosporin is an effective drug. Immunol. Today 14 (1993) 369
13. Esterbaur H., and Cheeseman K.H. Determination of aldehydic lipid peroxidation product: malonaldehyde and 4-hyroxynonenal. In: Packer L., and Glazer A.N. (Eds). Methods in Enzymology, vol. 186, Oxygen Radicals in Biological Systems (1990), Academic Press 407-421
14. Fadillioglu E., Erdogan H., Sogut S., and Kuku I. Protective effects of erdosteine against doxorubicin-induced cardiomyopathy in rats. J. Appl. Toxicol. 23 (2003) 71-74
15. Fadillioglu E., Yi{dotless}lmaz H.R., Erdogan H., and Sogut S. The activities xanthine oxidase and adenosine deaminase and the levels of hydroxproline and nitric oxide in rat hearts subjected to doxorubicin protective effect of erdostein. Toxicology 191 (2003) 153-158
16. Grieve D.J., and Shah A.M. Oxidative stress in heart failure. More than just damage. Eur. Heart J. 24 (2003) 2161-2163
17. Irmak M.K., Koltuksuz U., Kutlu N.O., Yagmurca M., Ozyurt H., Karaman A., and Akyol O. The effect of caffeic acid phenethyl ester on ischemia-reperfusion injury in comparison with alpha-tocopherol in rat kidneys. Urol. Res. 29 (2001) 190-193
18. Koc A., Duru M., Ciralik A., Akcan R., and Sogut S. Protective agent, erdosteine, against cisplatin-induced hepatic oxidant injury in rats. Mol. Cell. Biochem. 278 (2005) 79-84
19. Koc A., Narci A., Duru M., Gergerlioglu H.S., Akaydin Y., and Sogut S. The protective role of erdosteine on testicular tissue after testicular torsion and detorsion. Mol. Cell. Biochem. 280 (2005) 193-202
20. Levine R.L., Garland D., Oliver C.N., Amici A., Climent I., Lenz A.G., Ahn B.W., Shaltiel S., and Stantman E.R. Determination of carbonyl content in oxidatively modified proteins. In: Packer L., and Glazer A.N. (Eds). Methods in Enzimology, vol. 186, Oxygen Radicals in Biological Systems (1990), Academic Press, New York 464-478
21. Lowry O.H., Rosebrough N.J., Farr A.L., and Randall R.J. Protein measuremnet with the folin-phenol reagent. J. Biol. Chem. 193 (1951) 265-275
22. Paglia D.E., and Valentine W.N. Studies on the quantitative and qualitative characterisation of erythrocyte glutathione peroxidase. J. Lab. Clin. Med. 70 (1967) 158-169
23. Rezzani R. Cyclosporine A and adverse effects on organs. Histochemical studies. Prog. Histochem. Cytochem. 39 (2004) 85-128
24. Rezzani R., Giugno L., Buffoli B., Bonomini F., and Bianchi R. The protective effect of caffeic acid phenethyl ester against cyclosporine A-induced cardiotoxicity in rats. Toxicology 212 (2005) 155-164
25. Rezzani R., Rodella L., Dessy C., Daneau G., Bianch R., and Feron O. Changes in Hsp90 expression determine the effects of cyclosporine A on the NO pathway in rat myocardium. FEBS Lett. 552 (2003) 125-129
26. Sogut S., Ozyurt H., Akyol O., Kart L., İraz M., and Yildirim Z. Protection of erdosteine on bleomycine-induced lung fibrosis in rats. Eur. Res. J. 20 suppl 38 (2002) 487
27. Sun Y., Oberley L.W., and Ying L. A simple method for clinical assay of superoxide dismutase. Clin. Chem. 34 (1988) 497-500
28. Sener G., Aksoy H., Sehirli O., Yuksel M., Aral C., Gedik N., Cetinel S., and Yegen B.C. Erdosteine prevents colonic i{dotless}nflammation through i{dotless}ts antioxidant and free radical scavenging activities. Dig. Dis. Sci. 281 (2007) 129-137
29. Wang C., and Salahudeen A.K. Lipid peroxidation accompanies cyclosporine nephrotoxicity: effect of vitamin E. Kidney Int. 47 (1995) 927-934
30. Yagmurca M., Fadillioglu E., Erdogan H., Ucar M., Sogut S., and İrmak M.K. Erdosteine prevents doxorubicin-induced cardiotoxicity in rats. Pharmacol. Res. 48 (2003) 377-382
31. Yildirim Z., Sogut S., Odaci{dotless} E., Iraz M., Ozyurt H., and Kotuk M. Oral erdosteine administration attenuates cisplatin-induced renal tubular damage in rats. Pharmacol. Res. 47 (2003) 149-156
32. Yilmaz H.R., İraz M., Sogut S., Ozyurt H., Yildirim Z., and Akyol O. The effects of erdosteine on activities of some metabolic enzymes during cisplatin-induced nephrotoxicity in rats. Pharmacol. Res. 50 (2004) 287-290
33. Zachariane H. Renal toxicity of long-term cyclosporine. Scand. J. Rheumatol. 28 (1999) 65-68